Anyone know how the "time release works" - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > VARIOUS DRUGS > Opium, Opiates & Opioids
Register Tags Mark Forums Read

Notices

Opium, Opiates & Opioids Opium, codeine, hydrocodone and other opiates & opioids.

Reply
 
Thread Tools Display Modes
  #1  
Old 27-03-2005, 01:00
bartleman bartleman is offline
Newbie
 
Join Date: 23-02-2005
Location: Canada
Posts: 7
bartleman is an unknown quantity at this point
Points: 58, Level: 1 Points: 58, Level: 1 Points: 58, Level: 1
Activity: 0% Activity: 0% Activity: 0%
Hi, im just curious what makes the time release
work in say MS contin or Codeine Contin. Is it extra
ingredients or just the structure of the pill ?
Reply With Quote
  #2  
Old 28-03-2005, 05:22
moldie moldie is offline
Banned
 
Join Date: 31-01-2005
Location: United States
Posts: 197
moldie is an unknown quantity at this point
Points: 109, Level: 1 Points: 109, Level: 1 Points: 109, Level: 1
Activity: 0% Activity: 0% Activity: 0%


This article isn't exactly about any of the time released narcotics, but it is about the same time-release coating. It explains how it works in general, although it's emphasis is on ionic drugs.





Transport properties of ionic drugs in the ammonio methacrylate copolymer membranes.

Sun YM, Hsu SC, Lai JY.


Department of Chemical Engineering, Yuan Ze University, Chung-Li, Taoyuan, Taiwan, Republic of China. cesunym@saturn.yzu.edu.tw

PURPOSE: Ammonio methacrylate copolymer is a pharmaceutical excipient widely used as a coating material for encapsulation of pellet and tablet dosage forms. Because of the charged ammonio function groups within the polymer, ionic drugs may interact with the coating film while transporting through it. The kinetic swelling and drug permeation properties of the ammonio methacrylate copolymer membranes were studied to delineate the effect of ionic interaction between the ionic drugs and the membranes. METHODS: The pH and ionic strength of the solutions and the charged properties of drugs were varied to study the effects on the transport properties through the membranes. Ambroxol was chosen as a model cationic drug and aspirin as a model anionic drug. RESULTS: The degree of membrane swelling in the drug-free solution decreases as the ionic strength increases but it is irrelevant to the pH. With the presence of ionic drugs, the degree of membrane swelling is affected by the drug species as well as the pH of the solutions in addition to the effect of ionic strength. The degree of swelling for a membrane in a solution containing aspirin is higher at a lower pH and ambroxol is lower at a lower pH. Aspirin experiences a three-stage permeation and ambroxol a two-stage one. The ion-exchange reaction between the anionic carboxylic groups in aspirin and the cationic ammonio groups in the membranes results in a slow permeation stage during the transient state. The pseudo steady-state permeability for each drug follows the trend as the degree of membrane swelling in the drug media at various pH and ionic strengths. However, it is much higher for aspirin than ambroxol although the degree of membrane swelling is higher in an ambroxol solution than that in an aspirin solution. The permeability of ambroxol through the membrane is largely reduced because of the Donnan exclusion effect. CONCLUSIONS: The interaction between ionic drugs with the cationic groups in the membranes affects the ionic strength of the solutions and results in a pH-dependent degree of swelling. The ionic interaction also determines the drug permeation rates as well as the transient permeation behaviors.

PMID: 11442269 [PubMed - indexed for MEDLINE]
Reply With Quote
Reply

Bookmarks

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


Sitelinks: Site Functions:

All times are GMT +1. The time now is 04:51.


Copyright: Substance Information Network 2003 - 2009, All rights reserved